Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CRMD

CorMedix Inc

Jan 17 • 04:00PM ET

12.17

Dollar change -0.62
Percentage change -4.85	%

Healthcare • Biotechnology • USA • NASD

Peers: BCRX ADMA ANIP CTSO RMTI AMRX CRVS CLSD XTNT NAII

| Held by: IWM VTI VXF IWO IBB XPH VTWO IWC VFMO ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.80	Insider Own	2.16%	Shs Outstand	60.68M	Perf Week	8.76%
Market Cap	738.44M	Forward P/E	24.42	EPS next Y	0.50	Insider Trans	-9.56%	Shs Float	59.37M	Perf Month	46.45%
Income	-46.15M	PEG	-	EPS next Q	0.12	Inst Own	31.43%	Short Float	11.79%	Perf Quarter	16.46%
Sales	12.26M	P/S	60.23	EPS this Y	54.95%	Inst Trans	11.64%	Short Ratio	5.50	Perf Half Y	161.16%
Book/sh	1.01	P/B	12.00	EPS next Y	221.54%	ROA	-54.61%	Short Interest	7.00M	Perf Year	263.28%
Cash/sh	0.76	P/C	16.04	EPS next 5Y	-	ROE	-65.04%	52W Range	2.89 - 13.85	Perf YTD	50.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.58%	ROI	-78.08%	52W High	-12.13%	Beta	1.54
Dividend TTM	-	Quick Ratio	3.60	Sales past 5Y	-50.37%	Gross Margin	83.13%	52W Low	321.11%	ATR (14)	0.73
Dividend Ex-Date	-	Current Ratio	3.96	EPS Y/Y TTM	6.44%	Oper. Margin	-415.59%	RSI (14)	69.19	Volatility	7.37% 6.48%
Employees	82	Debt/Eq	0.01	Sales Y/Y TTM	41184.20%	Profit Margin	-376.35%	Recom	1.00	Target Price	16.83
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	72.61%	Payout	-	Rel Volume	1.36	Prev Close	12.79
Sales Surprise	10.73%	EPS Surprise	59.02%	Sales Q/Q	-	Earnings	Oct 30 BMO	Avg Volume	1.27M	Price	12.17
SMA20	27.40%	SMA50	23.33%	SMA200	72.24%	Trades		Volume	1,725,713	Change	-4.85%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-25	Initiated	D. Boral Capital	Buy	$15
Aug-26-24	Initiated	Rodman & Renshaw	Buy	$13
Aug-10-23	Initiated	RBC Capital Mkts	Outperform	$6
Feb-17-21	Initiated	Needham	Buy	$31
Sep-29-20	Initiated	JMP Securities	Mkt Outperform	$22
Sep-21-20	Initiated	Truist	Buy	$20
Dec-18-19	Initiated	B. Riley FBR	Buy	$48
Mar-26-19	Reiterated	H.C. Wainwright	Buy	$3 → $15
Dec-06-18	Initiated	ROTH Capital	Buy	$6
Sep-25-17	Reiterated	H.C. Wainwright	Buy	$3 → $4
Aug-10-17	Reiterated	Rodman & Renshaw	Buy	$5 → $3
May-05-17	Reiterated	Rodman & Renshaw	Buy	$6 → $5
Nov-11-16	Reiterated	FBR & Co.	Outperform	$6 → $4
Mar-17-16	Reiterated	FBR Capital	Outperform	$7 → $6
Mar-03-16	Initiated	FBR Capital	Outperform	$7
Nov-16-15	Reiterated	ROTH Capital	Neutral	$2.75 → $2.50
Oct-29-15	Reiterated	ROTH Capital	Neutral	$4.50 → $2.75
May-06-15	Downgrade	ROTH Capital	Buy → Neutral	$2.50 → $7.50
Dec-08-14	Reiterated	ROTH Capital	Buy	$3 → $2.50
Oct-03-11	Downgrade	Maxim Group	Buy → Hold

Show Previous Ratings

Jan-07-25 07:30AM	CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update (GlobeNewswire) +29.89%
Dec-20-24 07:21AM	CorMedix price target raised to $12 from $11 at RBC Capital (TipRanks)
Dec-19-24 08:30AM	CorMedix Inc. Added to Nasdaq Biotechnology Index (GlobeNewswire) +9.24%
Nov-26-24 08:30AM	CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products (GlobeNewswire)
Nov-04-24 08:30AM	CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium (GlobeNewswire)
03:07AM	Loading…
Oct-31-24 03:07AM	Cormedix Inc (CRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses (GuruFocus.com)
Oct-30-24 07:30AM	CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update (GlobeNewswire) -22.51%
Oct-29-24 09:13AM	Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-24-24 08:30AM	CorMedix Inc. Announces New Data at ASN Kidney Week 2024 (GlobeNewswire)
Oct-23-24 08:30AM	CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 (GlobeNewswire)
Oct-08-24 08:00AM	CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator (GlobeNewswire) +5.45%
Sep-19-24 08:00AM	CorMedix Inc. Announces New Commercial Agreement (GlobeNewswire)
Sep-13-24 08:30AM	CorMedix Inc. to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-09-24 10:52AM	CorMedix Inc. Announces New Commercial Agreement (GlobeNewswire)
Aug-14-24 07:30AM	CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update (GlobeNewswire) +30.16%
08:30AM	Loading…
Aug-07-24 08:30AM	CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024 (GlobeNewswire)
Jul-31-24 01:11PM	These 2 Strong Buy Penny Stocks Are Poised for a Big Rally, Say Analysts (TipRanks)
Jul-03-24 08:00AM	CorMedix Inc. Announces Outpatient Availability of DefenCath (GlobeNewswire)
Jun-18-24 08:00AM	CorMedix Inc. Receives FDA Feedback on Potential Label Expansion (GlobeNewswire)
Jun-06-24 08:30AM	CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath (GlobeNewswire)
May-28-24 08:30AM	CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider (GlobeNewswire)
May-13-24 11:08AM	CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 08:30AM	CorMedix Inc. to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-09-24 07:30AM	CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -5.17%
May-06-24 08:30AM	CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024 (GlobeNewswire)
May-02-24 09:55AM	Does CorMedix (CRMD) Have the Potential to Rally 135.51% as Wall Street Analysts Expect? (Zacks)
Apr-19-24 08:30AM	CorMedix Inc. Announces CMS Grants TDAPA to DefenCath (GlobeNewswire)
Apr-15-24 08:30AM	CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath (Taurolidine and Heparin) (GlobeNewswire) -7.88%
Apr-11-24 09:55AM	Wall Street Analysts Predict a 146.21% Upside in CorMedix (CRMD): Here's What You Should Know (Zacks) +21.02%
08:30AM	CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference (GlobeNewswire)
08:30AM	Loading…
Apr-08-24 08:30AM	CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC (GlobeNewswire)
Mar-27-24 08:30AM	CorMedix Inc. to Present at the Needham Annual Healthcare Conference (GlobeNewswire)
Mar-12-24 08:51AM	Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCath (GuruFocus.com)
07:30AM	CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 08:30AM	CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024 (GlobeNewswire)
Jan-30-24 08:30AM	CorMedix Inc. Announces Commercial and Reimbursement Updates (GlobeNewswire) -6.27%
Jan-08-24 08:30AM	CorMedix Inc. Announces Commercial and Operational Updates (GlobeNewswire) +6.49%
Dec-15-23 08:30AM	CorMedix Inc. Announces Appointment of Chief Legal Officer (GlobeNewswire)
Dec-04-23 08:30AM	CorMedix Inc. Announces Partnership With The Leapfrog Group (GlobeNewswire) +6.27%
Nov-15-23 12:57PM	CorMedix Inc. Announces FDA Approval of DefenCath to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients (GlobeNewswire) +6.39%
Nov-14-23 06:03PM	Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities in Q3 2023 (GuruFocus.com)
04:05PM	CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-23 08:30AM	CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023 (GlobeNewswire)
Oct-11-23 08:30AM	CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference (GlobeNewswire)
Sep-26-23 08:30AM	CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-08-23 08:30AM	CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology (GlobeNewswire)
Sep-06-23 08:30AM	CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference (GlobeNewswire)
Aug-30-23 08:00AM	CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath (GlobeNewswire)
Aug-10-23 10:12AM	Penn downgraded, Roblox upgraded: Wall Street's top analyst calls (The Fly)
Aug-08-23 07:30AM	CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.94%
Jul-26-23 08:30AM	CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023 (GlobeNewswire)
Jul-11-23 10:00AM	2 Strong Buy Penny Stocks With Massive 300% Upside Potential Or More (TipRanks)
Jun-28-23 10:57PM	CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) -22.29%
04:07PM	CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Jun-21-23 08:30AM	CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath (GlobeNewswire) +5.65%
Jun-15-23 08:30AM	Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections (GlobeNewswire) -5.14%
May-30-23 08:30AM	Cormedix Inc. To Present At The Jefferies Healthcare Conference (GlobeNewswire)
May-16-23 07:00AM	CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath (GlobeNewswire) -13.40%
May-15-23 04:05PM	CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-08-23 08:30AM	CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023 (GlobeNewswire) +6.06%
May-03-23 08:30AM	CorMedix Inc. to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-01-23 08:30AM	CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath (GlobeNewswire)
Apr-26-23 08:30AM	CorMedix Inc. Announces Regulatory, Manufacturing and Reimbursement Updates (GlobeNewswire) -8.97%
Apr-17-23 08:30AM	Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors (GlobeNewswire)
Mar-30-23 07:30AM	CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire) +13.11%
Mar-21-23 08:30AM	Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023 (GlobeNewswire)
Mar-02-23 04:05PM	CorMedix Inc. Announces Regulatory and Manufacturing Updates (GlobeNewswire)
Jan-17-23 08:30AM	CorMedix Inc. Announces Promotions in Commercial and Tech Ops (GlobeNewswire)
Dec-06-22 08:30AM	Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections (GlobeNewswire) -9.59%
Nov-12-22 07:44AM	CorMedix Third Quarter 2022 Earnings: US$0.17 loss per share (vs US$0.23 loss in 3Q 2021) (Simply Wall St.)
Nov-10-22 07:30AM	CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +9.19%
Nov-07-22 08:30AM	CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath (GlobeNewswire)
Nov-02-22 08:30AM	CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10 (GlobeNewswire)
Oct-20-22 08:30AM	CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference (GlobeNewswire)
Sep-07-22 08:30AM	CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference (GlobeNewswire) +5.33%
Aug-11-22 07:30AM	CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update (GlobeNewswire) +10.06%
Aug-09-22 07:01AM	CorMedix Slapped With Second FDA Rejection For DefenCath (Benzinga) -57.45%
Aug-08-22 04:05PM	CorMedix Inc. Announces Regulatory and Manufacturing Updates (GlobeNewswire) +5.47%
Aug-01-22 08:30AM	CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11 (GlobeNewswire)
Jul-11-22 06:32AM	We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely (Simply Wall St.) -6.94%
Jun-08-22 08:30AM	CorMedix to Participate at the JMP Securities Life Sciences Conference (GlobeNewswire)
May-12-22 04:01PM	CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +9.73%
08:30AM	CorMedix Inc. Announces Leadership Updates and Operational Changes (GlobeNewswire)
May-03-22 08:30AM	CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12 (GlobeNewswire)
Apr-07-22 08:30AM	CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development (GlobeNewswire)
Apr-04-22 08:30AM	CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:01PM	CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire) +5.60%
Mar-28-22 08:30AM	CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath (GlobeNewswire) -6.60%
Mar-22-22 08:30AM	CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results and Provide a Corporate Update on March 29 (GlobeNewswire)
Mar-17-22 08:30AM	CorMedix Inc. Announces the Appointment of Chief Executive Officer (GlobeNewswire)
Mar-10-22 10:55AM	2 Strong Buy Penny Stocks With Over 300% Upside Potential (TipRanks) +7.21%
Feb-28-22 12:42PM	CorMedix Refiles DefenCath US Application For Catheter-Related Bloodstream Infections (Benzinga) +21.39%
08:30AM	Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath (GlobeNewswire)
Feb-01-22 05:41AM	CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Jan-04-22 08:00AM	CorMedix to Participate in Upcoming January Conferences (GlobeNewswire)
Nov-09-21 04:05PM	CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-21 09:00PM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of Live Ventures, CorMedix, Emergent BioSolutions, and Generac on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm (GlobeNewswire)
08:30AM	CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9 (GlobeNewswire)
Oct-28-21 03:05PM	CorMedix (CRMD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
Oct-20-21 08:30AM	CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI (GlobeNewswire)

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mistry Erin	EVP, Chief Commercial Officer	Oct 31 '24	Buy	9.99	1,500	14,985	52,011	Dec 13 04:15 PM
Hurlburt Elizabeth	EVP	Nov 14 '24	Option Exercise	4.48	140,027	627,727	185,424	Nov 18 08:37 PM
Hurlburt Elizabeth	EVP	Nov 14 '24	Sale	11.18	140,027	1,565,670	45,397	Nov 18 08:37 PM
Hurlburt Elizabeth	Officer	Nov 14 '24	Proposed Sale	11.12	140,027	1,556,416		Nov 14 04:42 PM
Todisco Joseph	Chief Executive Officer	Mar 13 '24	Buy	3.74	13,561	50,718	352,839	Mar 14 08:45 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRMD

CorMedix Inc

Upgrade your FINVIZ experience